Clinical Trials Browser

Phase 1 × Lymphoma, B-Cell × CTLA-4 Antigen × Clear all

NCT01729806 2018-04-11

Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

Phase 1 Completed

Lymphoma, B-Cell